| External factors: | Doxorubicin |
| Aging type: | Accelerate |
| Aging characteristic: |
| Category: | Chemical compounds |
| Phenotype: | Synovial sarcoma |
| Experiment: | SA-β-gal activity assay |
| Description: | When control and doxorubicin-treated cultures were assayed for β-gal activity, only the FU-SY-1 SS cell line showed a significant (p<0.05) increase over controls in the percentage of cells considered β-gal positive. |
| Regulatory pathway: | -- |
| R-EF-Pathway: | -- |
| Pathway experiment: | -- |
| Pathway description: | -- |
Annotation: